HIV and AIDS Trial, Recruiting NCT00001281 Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT00001281
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older.
  • People who have suitable veins that allow blood to be drawn easily.
  • People whose blood pressure is at or below 180/100, and whose heart rate is between 50 and 100 beats per minute (a lower heart rate may still be acceptable if it is normal for that person).
  • People with adequate blood counts — specifically, a hemoglobin level of at least 9.0 g/dL and a platelet count of at least 50,000 (this applies to both people living with HIV and people not living with HIV).
  • People who are willing and able to sign a written consent form, follow all study requirements and procedures, and meet clinic policies.
  • People who are willing to allow their blood samples to be used for future research on HIV, and who agree to be screened for hepatitis.

Who may not be able to join:

  • People who are currently pregnant or breastfeeding.
  • People who currently have, or have a history of, substance abuse that could affect their ability to follow the study procedures or could put their safety at risk.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Susan L Moir, Ph.D., National Institute of Allergy and Infectious Diseases (NIAID)

Phone: (301) 402-3481

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
9 March 1993

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

The purpose of this protocol is to provide a mechanism to obtain blood products and other biologic samples that will be used by NIH Intramural Investigators in studies of HIV and other infectious or immune deficiency diseases

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov